The aim of the present article is to offer a critical and objective view on the use or abuse of patents and defensive strategies in the pharmaceutical industry. It shall also seek to establish whether patents as currently regulated offer an appropriate degree of protection of intellectual property (IP) held by the economic operators in the pharmaceutical sector and whether there is a need or, for that matter, scope for improvement.
World Competition